Session 1.3: Health Protection and Disease Prevention: A Critical Review of Experience

This is a summary of the presentations and discussion of Health Protection and Disease Prevention of the Conference, Health Aspects of the Tsunami Disaster in Asia, convened by the World Health Organization (WHO) in Phuket, Thailand, 04-06 May 2005. The topics discussed included issues related health protection and disease prevention as pertaining to the responses to the damage created by the Tsunami. It is presented in the following major sections:(1) key questions; (2) national perspectives; (3) an international perspective; (4) laboratory aspects in disease surveillance; and (5) partnershi

Probabilistic Inverse Method for Source Localization Applied to ETEX and the 2017 Case of Ru-106 including Analyses of Sensitivity to Measurement Data

In recent years, cases of unexplained, elevated levels of radioactive particles have demonstrated an increasing need for efficient and robust source localization methods. In this study, a Bayesian method for source localization is developed and applied to two cases. First, the method is validated against the European tracer experiment (ETEX) and then applied to the still unaccounted for release of Ru-106 in the fall of 2017. The ETEX dataset, however, differs significantly from the Ru-106 dataset with regard to time resolution and the distance from the release site to the nearest measurements. Therefore, sensitivity analyses are conducted in order to test the method’s sensitivity to these parameters. The analyses show that the resulting source localization depends on both the observed temporal resolution and the existence of sampling stations close to the source. However, the method is robust, in the sense that reducing the amount of information in the dataset merely reduces the accuracy, and hence, none of the results are contradictory. When applied to the Ru-106 case, the results indicate that the Southern Ural region is the most plausible release area, and, as hypothesized by other studies, that the Mayak nuclear facility is the most likely release location

Real-Time Quantitative PCR of Microdissected Paraffin-Embedded Breast Carcinoma : An Alternative Method for HER-2/neu Analysis

We studied the feasibility of using real-time quantitative PCR to determine HER-2 DNA amplification and mRNA expression in microdissected formalin-fixed, paraffin-embedded breast tumors and compared this with standard immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH) methods. Study cases (27 carcinomas and 3 ductal breast carcinoma in situ (DCIS) cases) showed varying Her-2 expression as determined by IHC (HercepTest). In carcinomas, there was a good correlation between HER-2 DNA amplification and strong HER-2 protein expression detected by FISH and IHC, respectively. A single DCIS case was amplified in FISH, but not in IHC. Both HER-2 gene amplification and expression could be quantified in microdissected paraffin-embedded tumors using real-time PCR, DNA and RNA being successfully detected in 146 of 150 (97%) and 141 of 150 (94%) samples, respectively. PCR analysis for HER-2 DNA amplification using the LightCycler HER2/neu DNA Quantification kit (Roche Molecular Biochemicals, Mannheim, Germany) correlated fairly well with IHC and FISH. All IHC HER-2 3+ tumors were amplified according to the kit, as was the FISH-amplified DCIS case. DNA-PCR identified five additional tumors as being amplified. Interestingly, all these scored 2+ with the HercepTest, but were negative using FISH. We believe that real-time quantitative PCR analysis of HER-2 DNA amplification following microdissection represents a useful supplementary or perhaps even an alternative technique for establishing HER-2 status in paraffin-embedded tumors